AbCellera Biologics (ABCL) Short Interest Ratio & Short Volume → get a piece of the profit from this land (From True Market Insiders) (Ad) Free ABCL Stock Alerts $3.64 -0.14 (-3.70%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AbCellera Biologics Short Interest DataCurrent Short Volume23,290,000 sharesPrevious Short Volume23,090,000 sharesChange Vs. Previous Month+0.87%Dollar Volume Sold Short$88.04 millionShort Interest Ratio / Days to Cover16.8Last Record DateApril 30, 2024Outstanding Shares294,050,000 sharesFloat Size205,970,000 sharesShort Percent of Float11.31%Today's Trading Volume1,041,106 sharesAverage Trading Volume1,438,343 sharesToday's Volume Vs. Average72% Short Selling AbCellera Biologics ? Sign up to receive the latest short interest report for AbCellera Biologics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABCL Short Interest Over TimeABCL Days to Cover Over TimeABCL Percentage of Float Shorted Over Time Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. AbCellera Biologics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202423,290,000 shares $88.04 million +0.9%11.3%16.8 $3.78 4/15/202423,090,000 shares $96.52 million -2.1%11.3%17.4 $4.18 3/31/202423,590,000 shares $106.86 million +2.4%11.5%16.7 $4.53 3/15/202423,040,000 shares $108.52 million +1.1%11.2%16 $4.71 2/29/202422,780,000 shares $115.04 million -0.1%11.1%14.8 $5.05 2/15/202422,810,000 shares $120.44 million -6.9%11.4%14.6 $5.28 Get the Latest News and Ratings for ABCL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AbCellera Biologics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202424,490,000 shares $125.14 million -2.3%12.3%16.8 $5.11 1/15/202425,070,000 shares $135.13 million -2.0%12.6%16.6 $5.39 12/31/202325,580,000 shares $146.06 million -3.2%12.9%16.7 $5.71 12/15/202326,420,000 shares $143.46 million -2.2%13.3%16.9 $5.43 11/30/202327,000,000 shares $127.17 million -1.7%13.6%16.8 $4.71 11/15/202327,470,000 shares $124.44 million -1.2%13.9%17.8 $4.53 10/31/202327,810,000 shares $114.30 million +5.5%14.0%17 $4.11 10/15/202326,370,000 shares $112.34 million +2.5%13.4%15 $4.26 9/30/202325,720,000 shares $118.31 million +1.7%13.0%13.6 $4.60 9/15/202325,290,000 shares $135.05 million -4.2%12.8%12.4 $5.34 8/31/202326,390,000 shares $143.83 million -4.2%13.4%10 $5.45 8/15/202327,550,000 shares $152.08 million +4.3%14.0%9.2 $5.52 7/31/202326,410,000 shares $204.15 million +4.9%13.4%8.3 $7.73 7/15/202325,170,000 shares $180.22 million -0.3%12.8%8.1 $7.16 6/30/202325,240,000 shares $163.05 million -12.9%12.8%8.7 $6.46 6/15/202328,960,000 shares $216.62 million +11.5%14.7%10.3 $7.48 5/31/202325,970,000 shares $181.01 million -2.4%13.2%12 $6.97 5/15/202326,620,000 shares $159.19 million +8.5%13.5%13.5 $5.98 4/30/202324,530,000 shares $166.31 million +4.0%12.5%14.1 $6.78 4/15/202323,590,000 shares $174.09 million +0.1%12.0%14.9 $7.38 3/31/202323,560,000 shares $177.64 million +2.2%12.0%14.4 $7.54 3/15/202323,050,000 shares $171.26 million +4.0%11.8%13.6 $7.43 2/28/202322,170,000 shares $186.23 million +9.0%11.3%12 $8.40 2/15/202320,340,000 shares $202.99 million +6.3%10.5%10.9 $9.98 1/31/202319,130,000 shares $201.44 million -2.8%9.9%10.1 $10.53 1/15/202319,680,000 shares $204.28 million +29.9%10.1%9.8 $10.38 12/30/202215,150,000 shares $153.47 million -1.3%7.8%7.6 $10.13 12/15/202215,350,000 shares $159.64 million -7.0%7.9%7.6 $10.40 11/30/202216,510,000 shares $212.48 million -7.3%8.5%8.7 $12.87 11/15/202217,800,000 shares $257.92 million -2.4%9.2%10.3 $14.49 10/31/202218,230,000 shares $215.66 million -6.7%9.4%10 $11.83 10/15/202219,530,000 shares $201.94 million +0.6%10.1%11.1 $10.34 9/30/202219,410,000 shares $191.96 million -10.2%10.1%10.6 $9.89 9/15/202221,620,000 shares $235.23 million +7.8%11.6%9.6 $10.88I’m afraid WWIII is a very real possibility (Ad)As one top U.S. cyber official claims: This [tech] is “the most powerful weapon of our time.” That's also why I've produced this new film.Take a look. ABCL Short Interest - Frequently Asked Questions What is AbCellera Biologics' current short interest? Short interest is the volume of AbCellera Biologics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 23,290,000 shares of ABCL short. 11.31% of AbCellera Biologics' shares are currently sold short. Learn More on AbCellera Biologics' current short interest. What is a good short interest ratio for AbCellera Biologics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABCL shares currently have a short interest ratio of 17.0. Learn More on AbCellera Biologics's short interest ratio. Which institutional investors are shorting AbCellera Biologics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbCellera Biologics: Walleye Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for AbCellera Biologics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.31% of AbCellera Biologics' floating shares are currently sold short. Is AbCellera Biologics' short interest increasing or decreasing? AbCellera Biologics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 23,290,000 shares, an increase of 0.9% from the previous total of 23,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is AbCellera Biologics' float size? AbCellera Biologics currently has issued a total of 294,050,000 shares. Some of AbCellera Biologics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AbCellera Biologics currently has a public float of 205,970,000 shares. How does AbCellera Biologics' short interest compare to its competitors? 11.31% of AbCellera Biologics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to AbCellera Biologics: Enliven Therapeutics, Inc. (18.60%), Prothena Co. plc (12.55%), Verona Pharma plc (7.56%), Collegium Pharmaceutical, Inc. (21.78%), Mirum Pharmaceuticals, Inc. (18.04%), Ironwood Pharmaceuticals, Inc. (13.04%), Belite Bio, Inc (0.06%), MannKind Co. (13.13%), Innoviva, Inc. (18.39%), Cassava Sciences, Inc. (28.91%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short AbCellera Biologics stock? Short selling ABCL is an investing strategy that aims to generate trading profit from AbCellera Biologics as its price is falling. ABCL shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AbCellera Biologics? A short squeeze for AbCellera Biologics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ABCL, which in turn drives the price of the stock up even further. How often is AbCellera Biologics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABCL, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Enliven Therapeutics Short Squeeze Prothena Short Squeeze Verona Pharma Short Squeeze Collegium Pharmaceutical Short Squeeze Mirum Pharmaceuticals Short Squeeze Ironwood Pharmaceuticals Short Squeeze Belite Bio Short Squeeze MannKind Short Squeeze Innoviva Short Squeeze Cassava Sciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABCL) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & Company4 Cryptos BETTER than BitcoinTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsProtect Your Bank Account Before It’s Too LateWeiss RatingsUrgent Nvidia WarningAltimetry